advertisement

Topcon

Oddone F 9

Showing records 1 to 9 | Display all abstracts from Oddone F

104273 A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy
Holló G
Current Medical Research and Opinion 2022; 38: 1189-1201
104348 The current use of glaucoma virtual clinics in Europe
Azzopardi M; Prokosch-Willing V
Eye 2023; 37: 1350-1356
104273 A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy
Kirwan J; Lopez-Lopez F
Current Medical Research and Opinion 2022; 38: 1189-1201
104348 The current use of glaucoma virtual clinics in Europe
Michelessi M; Fea AM
Eye 2023; 37: 1350-1356
104273 A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy
Zimina M
Current Medical Research and Opinion 2022; 38: 1189-1201
104348 The current use of glaucoma virtual clinics in Europe
Oddone F
Eye 2023; 37: 1350-1356
104273 A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy
Fassari C; Oddone F
Current Medical Research and Opinion 2022; 38: 1189-1201
104348 The current use of glaucoma virtual clinics in Europe
Mercieca K
Eye 2023; 37: 1350-1356
104273 A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy

Current Medical Research and Opinion 2022; 38: 1189-1201

Issue 23-2

Change Issue


advertisement

Oculus